Form 8-K - Current report:
SEC Accession No. 0001654954-23-001434
Filing Date
2023-02-07
Accepted
2023-02-07 16:31:03
Documents
22
Period of Report
2023-02-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tenx_8k.htm   iXBRL 8-K 33732
2 WARRANT AGENCY AGREEMENT tenx_ex41.htm EX-4.1 105031
3 PRE FUNDED WARRANT tenx_ex42.htm EX-4.2 95874
4 COMMON WARRANT tenx_ex43.htm EX-4.3 103765
5 PLACEMENT AGENCY AGREEMENT tenx_ex101.htm EX-10.1 96064
6 SECURITIES PURCHASE AGREEMENT tenx_ex102.htm EX-10.2 203467
7 FORM OF LEAK OUT tenx_ex103.htm EX-10.3 20762
8 PRICING PRESS RELEASE tenx_ex991.htm EX-99.1 13683
14 tenx_ex991img1.jpg GRAPHIC 4928
  Complete submission text file 0001654954-23-001434.txt   984652

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA tenx-20230203.xsd EX-101.SCH 5720
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tenx-20230203_lab.xml EX-101.LAB 14667
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tenx-20230203_cal.xml EX-101.CAL 898
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tenx-20230203_pre.xml EX-101.PRE 9275
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tenx-20230203_def.xml EX-101.DEF 2099
16 EXTRACTED XBRL INSTANCE DOCUMENT tenx_8k_htm.xml XML 3611
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34600 | Film No.: 23595489
SIC: 2834 Pharmaceutical Preparations